VEGFR-2 expression in human melanoma: revised assessment (Q30423356)

7 September 2017

VEGFR-2 expression in human melanoma: revised assessment (English)

1 reference

7 September 2017

7

Craig L Slingluff

1 reference

7 September 2017

Kerrington R Molhoek

1

1 reference

7 September 2017

Gulsun Erdag

2

1 reference

7 September 2017

J K Rasamny

3

1 reference

7 September 2017

Cheryl Murphy

4

1 reference

7 September 2017

Donna Deacon

5

1 reference

7 September 2017

James W Patterson

6

1 reference

7 September 2017

David L Brautigan

8

1 reference

7 September 2017

language of work or name

English

0 references

publication date

5 May 2011

1 reference

International Journal of Cancer

7 September 2017

1 reference

7 September 2017

129

1 reference

7 September 2017

12

1 reference

7 September 2017

2807-2815

1 reference

Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays

7 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

Sorafenib in advanced clear-cell renal-cell carcinoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

Pathways targeting tumor lymphangiogenesis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

Receptor tyrosine kinase inhibitors as anti-angiogenic agents.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

Localization of integrin alpha(v)beta3 and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in cutaneous and oral melanomas of dog.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

Endothelial progenitor cells: mobilization, differentiation, and homing

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

Receptor tyrosine kinases as target for anti-cancer therapy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

The epidemiology of skin cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

Enhanced expression of vascular endothelial growth factor in metastatic melanoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205910

FOXP3 immunohistochemistry on formalin-fixed paraffin-embedded tissue: poor correlation between different antibodies.

20 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FIJC.25963

VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FIJC.25963

VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas

21 January 2018

1 reference

12 December 2020

Survival Differences Between Patients With Scalp or Neck Melanoma and Those With Melanoma of Other Sites in the Surveillance, Epidemiology, and End Results (SEER) Program

1 reference

12 December 2020

The role of vascular endothelial growth factors and their receptors in malignant melanomas

1 reference

12 December 2020

Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors

1 reference

12 December 2020

Simultaneous blockade of VEGFR-1 and VEGFR-2 activation is necessary to efficiently inhibit experimental melanoma growth and metastasis formation

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.25963

1 reference

7 September 2017

1 reference

7 September 2017

PubMed publication ID

21544800

1 reference